Prediction of Poor Responders to Neoadjuvant Chemotherapy in Patients with Osteosarcoma: Additive Value of Diffusion-Weighted MRI including Volumetric Analysis to Standard MRI at 3T-Reference-Cited by-同舟云学术

Prediction of Poor Responders to Neoadjuvant Chemotherapy in Patients with Osteosarcoma: Additive Value of Diffusion-Weighted MRI including Volumetric Analysis to Standard MRI at 3T

Published:2020-03-10 Issue:3 Volume:15 Page:e0229983
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Lee Seul Ki^ORCID,Jee Won-Hee^ORCID,Jung Chan Kwon,Im Soo Ah,Chung Nack-Gyun,Chung Yang-Guk

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference34 articles.

1. Pattern of relapse in patients with osteosarcoma of the extremities treated with neoadjuvant chemotherapy;G Bacci;European journal of cancer (Oxford, England: 1990),2001

2. Management of osteosarcoma;J Whelan;Curr Treat Options Oncol,2006

3. Primary osteogenic sarcoma: pathologic aspects in 20 patients after treatment with chemotherapy en bloc resection, and prosthetic bone replacement;AG Huvos;Arch Pathol Lab Med,1977

4. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy;G Rosen;Cancer,1982

5. Imaging assessment of the response of bone tumors to preoperative chemotherapy;A Kawai;Clin Orthop Relat Res,1997

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the neoadjuvant chemotherapy response in osteosarcoma using the MRI DWI-based machine learning radiomics nomogram;Frontiers in Oncology;2024-03-21

2. Synovial Sarcoma in the Extremity: Diversity of Imaging Features for Diagnosis and Prognosis;Cancers;2023-10-05

3. Imaging Assessment of the Efficacy of Chemotherapy in Primary Malignant Bone Tumors: Recent Advances in Qualitative and Quantitative Magnetic Resonance Imaging and Radiomics;Journal of Magnetic Resonance Imaging;2023-05-08

4. Pitfalls of Diffusion-Weighted Imaging: Clinical Utility of T2 Shine-through and T2 Black-out for Musculoskeletal Diseases;Diagnostics;2023-05-07

5. Methodological considerations on segmenting rhabdomyosarcoma with diffusion-weighted imaging—What can we do better?;Insights into Imaging;2023-01-31